Overall objectives: Accelerate diagnosis and personalise management of inherited metabolic diseases.

Primary output: Clinically validated decision support tools enabling accelerated diagnosis and personalised management of inherited metabolic diseases, based on genomic, proteomic, and metabolomic data-driven computational models.

Sustainability: Development of academic technology to meet medical regulatory standards and a roadmap for exploitation within a European foundation to aid personalised diagnosis and management of inherited metabolic diseases.

Implemented by: A group of world-class scientists and clinicians from a diversity of disciplines who have collaborated multiple times and have a track record of leading key national and EU-funded initiatives to deliver high-impact results.